Healthcare Value Capital’s Labcorp LH Stock Holding History

Healthcare Value Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-29,100	Closed	-$3.16M	–	23
2020 Q1	$3.16M	Buy	+29,100	New	+$4.19M	5.32%	9

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Healthcare Value Capital's LH Position: Q2 2020 in Review

Healthcare Value Capital sold out of Labcorp (LH) in Q2 2020, closing a stake of 29,100 shares — an estimated $3.16M sold.

Healthcare Value Capital first reported a position in LH in Q1 2020 and held it in 1 quarter. The position peaked at $3.16M in Q1 2020. 798 funds tracked by Wall St. Rank hold LH as of Q2 2020.

Healthcare Value Capital reported no remaining Labcorp position as of Q2 2020 after selling out during the quarter.
Healthcare Value Capital sold 29,100 Labcorp shares in Q2 2020, an estimated $3.16M.
Healthcare Value Capital first reported a position in Labcorp in Q1 2020 and held it in 1 quarter.
Healthcare Value Capital's Labcorp position peaked at $3.16M in Q1 2020.
798 funds tracked by Wall St. Rank held Labcorp as of Q2 2020.

Based on Healthcare Value Capital's 13F filing for Q2 2020, filed 14 Aug 2020.